Home - Products - Angiogenesis - PKC - Phorbol 12-myristate 13-acetate

Phorbol 12-myristate 13-acetate

CAS No. 16561-29-8

Phorbol 12-myristate 13-acetate( PMA )

Catalog No. M12527 CAS No. 16561-29-8

A PKC activator, including group A (α, βI, βII, γ) and group B (δ, ε, η, θ) isoforms.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 80 In Stock
10MG 116 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Phorbol 12-myristate 13-acetate
  • Note
    Research use only, not for human use.
  • Brief Description
    A PKC activator, including group A (α, βI, βII, γ) and group B (δ, ε, η, θ) isoforms.
  • Description
    A PKC activator, including group A (α, βI, βII, γ) and group B (δ, ε, η, θ) isoforms; a potent tumor promoter often employed in biomedical research.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    PMA
  • Pathway
    Angiogenesis
  • Target
    PKC
  • Recptor
    PKC
  • Research Area
    Inflammation/Immunology
  • Indication
    ——

Chemical Information

  • CAS Number
    16561-29-8
  • Formula Weight
    616.825
  • Molecular Formula
    C36H56O8
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO: ≥ 62 mg/mL
  • SMILES
    CCCCCCCCCCCCCC(O[C@]1([H])[C@@]([C@@]2(O)[C@@]([C@]([C@@]13OC(C)=O)([H])C3(C)C)([H])C=C(CO)C[C@@]4(O)[C@@]2([H])C=C(C4=O)C)([H])C)=O
  • Chemical Name
    Tetradecanoic acid, (1aR,1bS,4aR,7aS,7bS,8R,9R,9aS)-9a-(acetyloxy)-1a,1b,4,4a,5,7a,7b,8,9,9a-decahydro-4a,7b-dihydroxy-3-(hydroxymethyl)-1,1,6,8-tetramethyl-5-oxo-1H-cyclopropa[3,4]benz[1,2-e]azulen-9-yl ester

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Xu F, et al. Br J Pharmacol. 2003 Sep;140(2):413-21. 2. Blumberg PM, et al. Cancer Res. 1988 Jan 1;48(1):1-8. 3. Niedel JE, et al. Proc Natl Acad Sci U S A. 1983 Jan;80(1):36-40.
molnova catalog
related products
  • Bisindolylmaleimide ...

    Bisindolylmaleimide III is a potent and selective inhibitor of protein kinase C (PKC), specifically interacting with PKCα or ribosomal S6 protein kinase 1 upon activation of these kinases.

  • NS 1209

    NS1209 is a AMPA receptor antagonist.

  • Valrubicin

    Valrubicin (AD 32) inhibits TPA- and PDBu-induced PKC activation (IC50s: 0.85 and 1.25 μM) and has antitumor and anti-inflammatory activity.